We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Highlights of Vol 4 | Issue 7 | 2026
The present study aimed to develop and validate a simple, precise, accurate, robust, and economical reverse-phase high-performance liquid chromatographic (RP-HPLC) method...
10.5281/zenodo.21323476 
The present study was aimed at the development and validation of a simple, precise, accurate, rapid, and economical Reverse Phase High Performance Liquid Chromatographic ...
10.5281/zenodo.21323270 
Nanosuspension terms divided into two words “Nano” and “suspension”. Nano refers to the particle size in the range of nanometres. Which is usually below 1000nm. W...
10.5281/zenodo.21323048 
Psoriasis is a chronic inflammatory skin disease caused by a complex interaction between genetic susceptibility, environmental factors, and immune dysregulation. It is ch...
10.5281/zenodo.21322910 
Loxapine succinate is a dibenzoxazepine antipsychotic agent widely used in the management of schizophrenia and acute agitation. Owing to its therapeutic importance and po...
10.5281/zenodo.21322822 
Quality by Design (QbD) has become the dominant framework for developing stability-indicating analytical methods for pharmaceutical dosage forms, replacing empirical one-...
10.5281/zenodo.21318565 
Background: Oral disintegrating and dispersible tablet technologies rely heavily on the choice of disintegrant to achieve rapid tablet breakup, fast dissolution, and impr...
10.5281/zenodo.21318463 
Background: Atypical antipsychotic drugs used in the management of schizophrenia and bipolar disorder are frequently associated with poor patient adherence, in part due t...
10.5281/zenodo.21318280 
Background: Ubrogepant and rimegepant are second-generation, orally administered calcitonin gene-related peptide (CGRP) receptor antagonists ("gepants") approved for the ...
10.5281/zenodo.21317933 
Analytical Quality by Design (AQbD) has emerged as a risk-based, regulatory-aligned framework for building robustness into reversed-phase high-performance liquid chromato...
10.5281/zenodo.21317728 
Chromatographic method development and validation entered a distinct new regulatory phase with the International Council for Harmonisation's split of the long-standing IC...
10.5281/zenodo.21314864 
Poor aqueous solubility affects an estimated 40% of marketed drugs and nearly 90% of molecules currently in the discovery pipeline, making dissolution-rate enhancement on...
10.5281/zenodo.21314731 